WhiteBook2_Part2 - 55

References
14. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019
(GBD 2019) Results. Institute for Health Metrics and Evaluation,
https://vizhub.healthdata.org/gbd-results/ (2020).
15. Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204
countries and territories, 1990-2019: a systematic analysis for the Global Burden of
Disease Study 2019. The Lancet 2020; 396: 1204-1222.
16. European Commission. What is Horizon 2020? Horizon 2020 - European Commission,
https://ec.europa.eu/programmes/horizon2020/en/what-horizon-2020 (2013,
accessed 11 February 2022).
17. European Union. Projects & results | CORDIS, https://cordis.europa.eu/projects/en
(accessed 12 February 2022).
18. Publications Office of the European Union. EU Vocabularies: European Science
Vocabulary (EuroSciVoc), https://op.europa.eu/en/web/eu-vocabularies/dataset//resource?uri=http://publications.europa.eu/resource/dataset/euroscivoc
(accessed
12 February 2022).
19. Clerx E, Kupfer SS, Leffler DA. Disparities Among Gastrointestinal Disorders in Research
Funding From the National Institutes of Health. Gastroenterology 2017; 153: 877-880.
20. Alatab S, Sepanlou SG, Ikuta K, et al. The global, regional, and national burden of
inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic
analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol
2020; 5: 17-30.
21. Hanna M. Matching Taxpayer Funding to Population Health Needs. Circ Res 2015; 116:
1296-1300.
22. McGregor S, Henderson KJ, Kaldor JM. How Are Health Research Priorities Set in Low
and Middle Income Countries? A Systematic Review of Published Reports. PLOS ONE
2014; 9: e108787.
23. Meirmans S, Butlin RK, Charmantier A, et al. Science policies: How should science
funding be allocated? An evolutionary biologists' perspective. J Evol Biol 2019; 32: 754-
768.
24. Carter AJ, Nguyen CN. A comparison of cancer burden and research spending reveals
discrepancies in the distribution of research funding. BMC Public Health 2012; 12: 526.
25. Ward D, Martino O, Packer C, et al. Burden of disease, research funding and innovation
in the UK: Do new health technologies reflect research inputs and need? J Health Serv
Res Policy 2013; 18: 7-13.
26. Ndugga N, Lightbourne TG, Javaherian K, et al. Disparities between research attention
and burden in liver diseases: implications on uneven advances in pharmacological
therapies in Europe and the USA. BMJ Open 2017; 7: e013620.
White Book 2: Part 2
52

https://vizhub.healthdata.org/gbd-results/ https://ec.europa.eu/programmes/horizon2020/en/what-horizon-2020 https://cordis.europa.eu/projects/en https://op.europa.eu/en/web/eu-vocabularies/dataset/-/resource?uri=http://publications.europa.eu/resource/dataset/euroscivoc https://op.europa.eu/en/web/eu-vocabularies/dataset/-/resource?uri=http://publications.europa.eu/resource/dataset/euroscivoc

WhiteBook2_Part2

Table of Contents for the Digital Edition of WhiteBook2_Part2